The Santa Cruz Trilogy →
Top Entrepreneurs' Advice →
Support Xconomy Detroit →
Boston Angel Investors →
Incubator Guide →
Director, Life Sciences Institute, University of Michigan
CEO and Fund Manager, Renaissance Venture Capital Fund
Chairman, CEO, & Founder, Alexandria Real Estate Equities
Managing director, the Foundry Group
Co-Founder, VP of Technology, Entropic Communications
VP of Research & Policy, Ewing Marion Kauffman Foundation
Exelixis (NASDAQ: EXEL) is a South San Francisco biotechnology company developing drugs for thyroid cancer, prostate cancer, and other conditions.
Seattle · 04/22/142:45 pm - 6:00 pm
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2014, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.